Newsroom
Off the wire.
An independent desk on the people, policy, and money moving cannabis, plus the science that cuts through the noise.
BusinessAn Illinois dispensary chain's co-founder just traded his cannabis license for a prison sentence
David Berger booked private jets with cocaine cash for a Mexican trafficker — now he's out at Ivy Hall and headed to federal prison.
3mo ago · 4 min read
PolicyGeorgia just rewrote its medical marijuana rules — no more THC cap, vaping's in
SB 220 took effect July 1, swapping a 5% potency ceiling for a possession limit and adding four new qualifying conditions.
3mo ago · 4 min read
BusinessCannabis stocks are up 103% this year — and it's all riding on one hearing
The MSOS ETF hit its 2026 high as investors position ahead of the DEA's rescheduling decision, with Trulieve's NYSE debut leading the way.
3mo ago · 5 min read
ScienceThe biggest weed-and-your-heart review yet says: still complicated, but watch the arrhythmias
Mayo Clinic researchers pooled a decade of cardiovascular studies and found the clearest signal isn't heart attacks or strokes — it's irregular heartbeats.
3mo ago · 5 min read
DropsA $60 vape that took two years to make: inside Jaunty's live resin bet
The New York brand scrapped an earlier version before launching two sun-grown live resin cartridges — and it wants regulators to define what "live resin" even means.
3mo ago · 4 min read
ScienceNew receptor-level data backs up what dabbers have been saying for years about terpenes
A Biochemical Pharmacology paper found THC and specific terpenes act together at the receptor level — early evidence, not proof, for the entourage effect.
3mo ago · 5 min read
PolicyRescheduling is moving — here’s what actually changes for your shop
Past the headlines: the tax, banking, and research knock-on effects that hit dispensaries and brands first.
3mo ago · 6 min read
DropsOn deck this week: the drops worth crossing town for
A rundown of the limited releases landing in the markets we cover.
3mo ago · 2 min read
CultureThe UN's new numbers say cannabis is still winning the global drug-of-choice race
256 million people used cannabis in 2024 — more than opioid, amphetamine, cocaine, and ecstasy users combined.
3mo ago · 4 min read
PolicyMassachusetts could become the first state to repeal legalization — and it’s now on the ballot
Anti-legalization advocates turned in enough signatures to put a recreational-cannabis repeal in front of voters this November.
3mo ago · 5 min read
BusinessWall Street is finally taking the call: Glass House cleared for the NYSE
Weeks after Trulieve became the first U.S. plant-touching operator to list on the Big Board, Glass House Brands got the nod too.
3mo ago · 5 min read
Culture300 workers just staged the first-ever Teamsters strike at a cannabis grow house
Ascend Wellness's cultivation facility in downstate Illinois feeds dispensaries statewide — and it's been on strike since 2 a.m. Thursday.
3mo ago · 4 min read